| Description | Q8 is an antagonist of cysteinyl leukotreine receptor. Q8 inhibits VEGF-independent angiogenesis. |
| Synonyms | Q8 |
| molecular weight | 299.75 |
| Molecular formula | C17H14ClNO2 |
| CAS | 1541762-55-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Dugel PU, Jaffe GJ, Sallstig P, Warburton J, Weichselberger A, Wieland M, Singerman L. Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial. Ophthalmology. 2017 May 24. pii: S0161-6420(16)32413-7. doi: 10.1016/j.ophtha.2017.03.057. [Epub ahead of print] PubMed PMID: 28551167. 2. Choi SK, Schurig-Briccio L, Ding Z, Hong S, Sun C, Gennis RB. Location of the substrate binding site of the cytochrome bo(3) ubiquinol oxidase from Escherichia coli. J Am Chem Soc. 2017 May 24. doi: 10.1021/jacs.7b03883. [Epub ahead of print] PubMed PMID: 28538096. 3. de Vink P, Briels J, Schrader T, Milroy L, Brunsveld L, Ottmann C. Cucurbit[8]uril and 14-3-3 based binary bivalent supramolecular-protein assembly platform and co-crystal structure. Angew Chem Int Ed Engl. 2017 May 16. doi: 10.1002/anie.201701807. [Epub ahead of print] PubMed PMID: 28510303. 4. Zhao M, Lepak AJ, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Target Assessment of Eravacycline against Escherichia Coli in a Murine Thigh Infection Model. Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.00250-17. doi: 10.1128/AAC.00250-17. [Epub ahead of print] PubMed PMID: 28416552. |